Efficacy and Safety of Perampanel as Early Adjunctive Therapy in Chinese Patients with Partial Onset Seizures - The Interim Analysis

被引：0
|
作者：
Gao, Lehong [1 ]
Wang, Yuping [1 ]
Lu, Qiang [2 ]
Wang, Guoping [3 ]
Wang, Zan [4 ]
Yue, Wei [5 ]
机构：
[1] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China
[2] Peking Union Med Coll Hosp, Beijing, Peoples R China
[3] Anhui Prov Hosp, Hefei, Anhui, Peoples R China
[4] Jilin Univ, Bethune Hosp 1, Changchun, Peoples R China
[5] Tianjin Huanhu Hosp, Tianjin, Peoples R China
来源：
ANNALS OF NEUROLOGY | 2022年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
S149
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures
    Baulac, Michel
    Leppik, Iio E.
    EPILEPSY RESEARCH, 2007, 75 (2-3) : 75 - 83
  • [22] Zonisamide as Adjunctive Therapy for Adults with Partial-Onset Epileptic Seizures: An Efficacy and Safety Review
    Vossler, David G.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 331 - 339
  • [23] A Multicenter, Randomized Phase III Trial Evaluating the Efficacy and Safety of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Patients with Refractory Partial-Onset Seizures
    Krauss, Gregory L.
    Serratosa, Jose M.
    Villanueva, Vicente E.
    Endziniene, Milda
    Hong, Zhen
    French, Jacqueline
    Yang, Haichen
    Squillacote, David
    Zhu, Jin
    Laurenza, Antonio
    NEUROLOGY, 2011, 76 (09) : A615 - A615
  • [24] Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase III studies
    Steinhoff, Bernhard J.
    Ben-Menachem, Elinor
    Ryvlin, Philippe
    Shorvon, Simon
    Kramer, Lynn
    Satlin, Andrew
    Squillacote, David
    Yang, Haichen
    Zhu, Jin
    Laurenza, Antonio
    EPILEPSIA, 2013, 54 (08) : 1481 - 1489
  • [25] PERPRISE (PERampanel in patients with PRImary or SEcondarily generalised seizures): first interim analysis of the observational study assessing perampanel as the only adjunctive therapy
    Steinhoff, B. J.
    Goldmann, T.
    Winter, Y.
    EPILEPSIA, 2023, 64 : 295 - 295
  • [26] Determination of Tolerability, Safety, and Efficacy of Perampanel, a Selective AMPA Receptor Antagonist, as Adjunctive Therapy in Subjects with Refractory Partial Seizures
    Krauss, Gregory L.
    Biton, Victor
    Klapper, Jack A.
    Bar, Michael
    Rektor, Ivan
    Vaiciene-Magistris, Nerija
    Skaringa, Algimantas
    Liigant, Aive
    Kumar, Dinesh
    Squillacote, David
    NEUROLOGY, 2009, 72 (11) : A442 - A442
  • [27] DETERMINATION OF TOLERABILITY, SAFETY, AND EFFICACY OF PERAMPANEL, A SELECTIVE AMPA RECEPTOR ANTAGONIST, AS ADJUNCTIVE THERAPY IN SUBJECTS WITH REFRACTORY PARTIAL SEIZURES
    Krauss, G.
    Biton, V.
    Klapper, J.
    Bar, M.
    Rektor, I.
    Vaiciene-Magistris, N.
    Liigant, A.
    Kumar, D.
    Squillacote, D.
    EPILEPSIA, 2009, 50 : 103 - 103
  • [28] PerampanelAs Adjunctive Therapy in Patients with Partial-Onset Seizures
    Greg L. Plosker
    CNS Drugs, 2012, 26 : 1085 - 1096
  • [29] Efficacy and safety of rufinamide as adjunctive therapy for inadequately controlled partial seizures in pediatric patients
    Glauser, T
    Arzimanoglou, A
    Litzinger, M
    Frank, LM
    Vigevano, F
    Perdomo, C
    Arroyo, S
    EPILEPSIA, 2005, 46 : 194 - 195
  • [30] Efficacy and safety of rufinamide as adjunctive therapy in adult patients with inadequately controlled partial seizures
    Brodie, MJ
    Rosenfeld, W
    Vazquez, B
    Ko, D
    Perdomo, C
    Arroyo, S
    NEUROLOGY, 2006, 66 (05) : A35 - A36
12345